Replies to post #92489 on Biotech Values

[DewDiligence]

BSX has resumed ICD sales, but its market-share loss to MDT and STJ may be long-lived:

http://finance.yahoo.com/news/Boston-Scientific-to-prnews-1429949208.html?x=0&.v=1